Aytu Biopharma Inc expected to post a loss of 63 cents a share - Earnings Preview

Aytu Biopharma

10/05/2023 03:03

* Aytu Biopharma Inc  AYTU.OQ   AYTU.O  is expected to show
a rise
in quarterly revenue when it reports  results on May 11. 
    * The Englewood Colorado-based  company is expected to
report  a
15.7% increase in revenue to $28 million from $24.2 million a
year ago, according to the estimate from one analyst, based on
Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Aytu Biopharma Inc
is for
a loss of 63 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Aytu
Biopharma
Inc is $70​, above​ its last closing price of $2.05. ​​​

This summary was machine generated May 10 at 02:03 GMT.  All
figures in US dollars  unless otherwise stated